Serum Angptl2 and CyPA Levels in Acute Myocardial Infarction and In-Stent Restenosis After Percutaneous Coronary Intervention: A Single-Center Retrospective Case-Control Study
Vascular Health and Risk Management · 2025
DOI: 10.2147/vhrm.s511648 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Vascular Health and Risk Management, 2025. Verfasst von Pimo Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie City, Guizhou Province, People's Republic of China. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Angiopoietin-like Proteins, Coronary Restenosis, Stents. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine, Zhejiang Provincial People's Hospital Bijie Hospital, Bijie City, Guizhou Province, People's Republic of China.
ORCID-Profile: Bo Zhou
Zitieren
APA
Zhou, P., Yang, T., Huang, H., Tang, F., Jin, P., & Zhou, B. (2025). Serum Angptl2 and CyPA Levels in Acute Myocardial Infarction and In-Stent Restenosis After Percutaneous Coronary Intervention: A Single-Center Retrospective Case-Control Study. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s511648
Vancouver
Zhou P, Yang T, Huang H, Tang F, Jin P, Zhou B. Serum Angptl2 and CyPA Levels in Acute Myocardial Infarction and In-Stent Restenosis After Percutaneous Coronary Intervention: A Single-Center Retrospective Case-Control Study. Vascular Health and Risk Management. 2025. doi:10.2147/vhrm.s511648
BibTeX
@article{Zhou2025,
author = {Zhou, Pimo and Yang, Tai and Huang, Hua and Tang, Fang and Jin, Peng and Zhou, Bo},
title = {Serum Angptl2 and CyPA Levels in Acute Myocardial Infarction and In-Stent Restenosis After Percutaneous Coronary Intervention: A Single-Center Retrospective Case-Control Study},
journal = {Vascular Health and Risk Management},
year = {2025},
doi = {10.2147/vhrm.s511648}
}
EUVIMED